Total submissions: 6
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Mayo Clinic Laboratories, |
RCV000724318 | SCV005412823 | uncertain significance | not provided | 2024-02-15 | criteria provided, single submitter | clinical testing | |
| New York Genome Center | RCV001542329 | SCV001761015 | uncertain significance | Progressive demyelinating neuropathy with bilateral striatal necrosis | 2020-06-26 | criteria provided, single submitter | clinical testing | |
| Labcorp Genetics |
RCV000724318 | SCV001683853 | likely benign | not provided | 2026-01-19 | criteria provided, single submitter | clinical testing | |
| Fulgent Genetics, |
RCV000765393 | SCV000896667 | uncertain significance | Amish lethal microcephaly; Progressive demyelinating neuropathy with bilateral striatal necrosis | 2018-10-31 | criteria provided, single submitter | clinical testing | |
| Gene |
RCV000724318 | SCV000565570 | uncertain significance | not provided | 2022-05-24 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge |
| Eurofins Ntd Llc |
RCV000724318 | SCV000231777 | uncertain significance | not provided | 2017-10-27 | criteria provided, single submitter | clinical testing |